Harrow HROW
NASDAQ HROW
$27.47 +0.58 (+2.16%)
At close: Nov 9, 2026 · 4:00 PM EST

Harrow (HROW) Asset Writedowns and Impairment (2016)

Updated

Harrow (HROW) recorded Asset Writedowns and Impairment of $380,000 in FY2023.

Analysis

Harrow (HROW) Asset Writedowns and Impairment (2016) Analysis & Trends

  • The FY2023 figure is the lowest annual Asset Writedowns and Impairment since FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn
10 Harrow 1.03 Bn 708.48 Mn 50.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2016 303,000.00
API Access

Harrow Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=HROW&period=max&api_key=YOUR_API_KEY